| |
| |
|
| Insider
Information: |
Albers Jeffrey W. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
180,202 |
|
|
Indirect Shares
|
34,360 |
|
|
| Direct
Value |
$18,481,113 |
|
|
|
Indirect Value
|
$20,640 |
|
|
| Total
Shares |
214,562 |
|
|
| Total
Value |
$18,501,753 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 151.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Blueprint Medicines Corp |
BPMC |
|
2024-03-20 |
176,050 |
|
0 |
Premium* |
|
|
Dianthus Therapeutics Ord Shs |
DNTH |
Director |
2018-06-25 |
4,152 |
2018-06-25 |
0 |
Premium* |
|
|
Aeglea Biotherapeutics, Inc. |
AGLE |
|
2023-11-24 |
0 |
2023-11-24 |
34,360 |
Premium* |
|
|
Kymera Therapeutics, Inc. |
KYMR |
|
2024-02-21 |
0 |
2024-01-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGLE |
Aeglea Biotherapeutics, I... |
|
– • – |
2023-11-24 |
4/A |
A |
$0.00 |
$0 |
I/I |
34,360 |
34,360 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO & PresidentOfficer |
• • – |
2015-04-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
143,486 |
|
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2015-11-02 |
4 |
AS |
$21.02 |
$210,200 |
D/D |
(10,000) |
133,486 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2015-11-10 |
4 |
AS |
$21.87 |
$153,090 |
D/D |
(7,000) |
126,486 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2016-04-06 |
4 |
AS |
$20.42 |
$347,140 |
D/D |
(17,000) |
109,486 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2016-06-03 |
4 |
AS |
$20.03 |
$340,510 |
D/D |
(17,000) |
92,486 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2016-08-08 |
4 |
AS |
$22.84 |
$388,663 |
D/D |
(17,000) |
75,486 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2017-03-14 |
4 |
AS |
$39.75 |
$800,516 |
D/D |
(20,000) |
55,486 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2017-06-28 |
4 |
AS |
$49.10 |
$1,009,394 |
D/D |
(20,000) |
35,486 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2017-08-07 |
4 |
AS |
$48.29 |
$981,637 |
D/D |
(20,000) |
15,486 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2017-08-08 |
4 |
AS |
$50.70 |
$507,000 |
D/D |
(10,000) |
5,486 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2017-11-06 |
4 |
AS |
$68.95 |
$2,109,251 |
D/D |
(30,000) |
0 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2017-11-06 |
4 |
OE |
$1.87 |
$45,841 |
D/D |
24,514 |
30,000 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2018-03-02 |
4 |
OE |
$1.87 |
$37,400 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2018-03-02 |
4 |
AS |
$88.17 |
$1,851,463 |
D/D |
(20,000) |
0 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2018-05-07 |
4 |
AS |
$78.56 |
$1,578,091 |
D/D |
(20,000) |
0 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2018-05-07 |
4 |
OE |
$1.87 |
$37,400 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2018-08-06 |
4 |
OE |
$1.87 |
$37,400 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2018-08-06 |
4 |
AS |
$68.48 |
$1,411,896 |
D/D |
(20,000) |
0 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2018-11-05 |
4 |
AS |
$62.66 |
$1,269,709 |
D/D |
(20,000) |
0 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2018-11-05 |
4 |
OE |
$1.87 |
$37,400 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2018-11-19 |
4 |
OE |
$1.87 |
$54,157 |
D/D |
28,961 |
28,961 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2019-03-15 |
4 |
AS |
$85.61 |
$1,727,884 |
D/D |
(20,000) |
28,961 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2019-03-15 |
4 |
OE |
$1.87 |
$37,400 |
D/D |
20,000 |
48,961 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
CEO and President |
• • – |
2019-06-12 |
4 |
AS |
$82.37 |
$1,694,906 |
D/D |
(20,000) |
28,961 |
0 |
- |
|
107 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
